Semantic loss marks early Alzheimer's disease-related neurodegeneration in older adults without dementia

被引:34
|
作者
Vonk, Jet M. J. [1 ,2 ]
Bouteloup, Vincent [3 ,4 ]
Mangin, Jean-Francois [5 ,6 ]
Dubois, Bruno [7 ]
Blanc, Frederic [8 ,9 ,10 ]
Gabelle, Audrey [11 ,12 ]
Ceccaldi, Mathieu [13 ,14 ]
Annweiler, Cedric [15 ,16 ,17 ,18 ,19 ]
Krolak-Salmon, Pierre [20 ]
Belin, Catherine [21 ]
Rivasseau-Jonveaux, Therese [22 ]
Julian, Adrien [23 ]
Sellal, Francois [24 ,25 ]
Magnin, Eloi [26 ,27 ]
Chupin, Marie [5 ]
Habert, Marie-Odile [5 ,28 ,29 ]
Chene, Genevieve [3 ,4 ]
Dufouil, Carole [3 ,4 ]
机构
[1] Columbia Univ, Coll Phys & Surg, Dept Neurol, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA
[2] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands
[3] Univ Bordeaux, Bordeaux Sch Publ Hlth, Inst Sante Publ, Ctr Inserm U1219,Epidemiol & Dev ISPED, Bordeaux, France
[4] Ctr Hosp Univ CHU Bordeaux, Pole Sante Publ, Bordeaux, France
[5] CATI Multictr Neuroimaging Platform, Paris, France
[6] Paris Saclay Univ, CEA, Neurospin, Gif Sur Yvette, France
[7] Sorbonne Univ, Grp Hosp Pitie Salpetriere, AP HP,Inst Cerveau & Moelle Epiniere, INSERM S975,IM2A,Inst Memoire & Maladie Alzheimer, Paris, France
[8] Hop Univ Strasbourg, CM2R Ctr Memoire Ressource & Rech, Hop Jour, Pole Geriatrie, Strasbourg, France
[9] CNRS, Lab ICube, UMR 7357, Strasbourg, France
[10] FMTS Federat Med Translat Strasbourg, Team IMIS, Strasbourg, France
[11] CHU Guide de Chauliac, Dept Neurol, Ctr Memoire Ressources Rech, Montpellier, France
[12] Univ Montpellier, Inserm U1061, Montpellier, France
[13] CHU Timone, AP HM, CMMR PACA Ouest, Marseille, France
[14] Aix Marseille Univ, INSERM, Inst Neurosci Syst, INS, Marseille, France
[15] Angers Univ Hosp, Dept Geriatr Med, Angers, France
[16] Angers Univ, Memory Clin, Angers, France
[17] Res Ctr Auton & Longev, Angers, France
[18] Univ Angers, UPRES EA 4638, Angers, France
[19] Univ Western Ontario, Schulich Sch Med & Dent, Dept Med Biophys, Robarts Res Inst, London, ON, Canada
[20] Univ Lyon 1, Hosp Civils Lyon, Ctr Memoire Ressources Rech Lyon, Inst Vieillissement,Inserm U1048, Lyon, France
[21] Hop St Louis, AP HP, Serv Neurol, Paris, France
[22] Univ Lorraine, CHRU Nancy, Ctr Memoire Ressources & Rech Lorraine, Unite Cognit Comportementale,Lab Lorrain Psychol, Nancy, France
[23] CHU La Miletrie, Serv Neurol, Ctr Memoire Ressources & Rech, Poitiers, France
[24] Hop Civils, CMRR Dept Neurol, Colmar, France
[25] Univ Strasbourg, Fac Med, INSERM U1118, Strasbourg, France
[26] CHRU Besancon, Serv Neurol, Ctr Memoire Ressources & Rech CMRR, Besancon, France
[27] Univ Bourgogne Franche Comte, Neurosci Integrat & Clin EA481, Besancon, France
[28] Sorbonne Univ, LIB, CNRS, Lab Imagerie Biomed,INSERM, Paris, France
[29] Hop La Pitie Salpetriere, AP HP, Med Nucl, Paris, France
基金
英国医学研究理事会;
关键词
Alzheimer's disease; amnestic; biomarkers; category fluency; cognitive aging; cohort studies; letter fluency; MCI; neuroimaging; semantic fluency; verbal fluency; WHITE-MATTER HYPERINTENSITIES; VERBAL FLUENCY PERFORMANCE; MILD COGNITIVE IMPAIRMENT; CATEGORY FLUENCY; DIFFERENTIAL IMPAIRMENT; MEMORY; PROGRESSION; DIAGNOSIS; BIOMARKER; PATTERNS;
D O I
10.1002/dad2.12066
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
ObjectiveTo assess progression of semantic loss in early stages of cognitive decline using semantic and letter fluency performance, and its relation with Alzheimer's disease (AD)-specific neurodegeneration using longitudinal multimodal neuroimaging measures. MethodsChange in verbal fluency was analyzed among 2261 non-demented individuals with a follow-up diagnosis of no mild cognitive impairment (MCI), amnestic MCI (aMCI), non-amnestic MCI (naMCI), or incident dementia, using linear mixed models across 4 years of follow-up, and relations with magnetic resonance imaging (MRI; n = 1536) and F-18-fluorodeoxyglucose brain positron emission tomography (F-18-FDG-PET) imaging (n = 756) using linear regression models across 2 years of follow-up. ResultsSemantic fluency declined-fastest in those at higher risk for AD (apolipoprotein E [APOE] e4 carriers, Clinical Dementia Rating score of .5, aMCI, or incident dementia)-while letter fluency did not except for those with incident dementia. Lower baseline semantic fluency was associated with an increase in white matter hyperintensities and total mean cortical thinning over time, and regionally with less hippocampal volume as well as more cortical thinning and reduced F-18-FDG-PET uptake in the inferior parietal lobule, entorhinal cortex, isthmus cingulate, and precuneus-posterior cingulate area. In contrast, baseline letter fluency was not associated with change in total nor regional neurodegeneration. Whole-brain neurodegeneration over time was associated with faster decline in both fluencies, while AD-specific regions were associated with a faster rate of decline in semantic but not letter fluency. InterpretationThis study provides strong evidence of distinctive degeneration of semantic abilities early on in relation to both cognitive decline and AD-specific neurodegeneration.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Association of Plasma Biomarkers of Alzheimer's Disease and Neurodegeneration with Physical Performance in Older Adults without Dementia.
    Parker, D.
    Faldowski, R.
    Morey, M.
    Sloane, R.
    Pieper, C.
    Hall, K.
    Cohen, H. J.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2020, 70 : S11 - S11
  • [3] The Role of β-Amyloid in Alzheimer's Disease-Related Neurodegeneration
    Goldsworthy, Mitchell R.
    Vallence, Ann-Maree
    JOURNAL OF NEUROSCIENCE, 2013, 33 (32): : 12910 - 12911
  • [4] Quality of opioid prescribing in older adults with or without Alzheimer disease and related dementia
    Yu-Jung Jenny Wei
    Siegfried Schmidt
    Cheng Chen
    Roger B. Fillingim
    M. Carrington Reid
    Steven DeKosky
    Laurence Solberg
    Marco Pahor
    Babette Brumback
    Almut G. Winterstein
    Alzheimer's Research & Therapy, 13
  • [5] Quality of opioid prescribing in older adults with or without Alzheimer disease and related dementia
    Wei, Yu-Jung Jenny
    Schmidt, Siegfried
    Chen, Cheng
    Fillingim, Roger B.
    Reid, M. Carrington
    DeKosky, Steven
    Solberg, Laurence
    Pahor, Marco
    Brumback, Babette
    Winterstein, Almut G.
    ALZHEIMERS RESEARCH & THERAPY, 2021, 13 (01)
  • [6] Effect of light therapy on delirium in older patients with Alzheimer's disease-related dementia
    Zou, Chenjun
    Mei, Xi
    Li, Xingxing
    Hu, Jun
    Xu, Ting
    Zheng, Chengying
    JOURNAL OF PSYCHIATRIC RESEARCH, 2022, 149 : 124 - 127
  • [7] Personal identity and memory in older adults without dementia and with Alzheimer's disease
    Salazar-Villanea, Monica
    ACTUALIDADES EN PSICOLOGIA, 2007, 21 (108): : 1 - 37
  • [8] The immunomodulatory effects of psychedelics in Alzheimer's disease-related dementia
    Hosseini, Alireza Mohammad
    Khaleghzadeh-Ahangar, Hossein
    Rahimi, Atena
    NEUROSCIENCE, 2025, 564 : 271 - 280
  • [9] Plasma amyloid, tau, and neurodegeneration biomarker profiles predict Alzheimer's disease pathology and clinical progression in older adults without dementia
    Shen, Xue-Ning
    Li, Jie-Qiong
    Wang, Hui-Fu
    Li, Hong-Qi
    Huang, Yu-Yuan
    Yang, Yu-Xiang
    Tan, Lan
    Dong, Qiang
    Yu, Jin-Tai
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2020, 12 (01)
  • [10] The underlying mechanisms of semantic memory loss in Alzheimer's disease and semantic dementia
    Rogers, Sean L.
    Friedman, Rhonda B.
    NEUROPSYCHOLOGIA, 2008, 46 (01) : 12 - 21